Novel Biomarkers and Therapeutic Approaches for Diabetic Retinopathy and Nephropathy: Recent Progress and Future Perspectives
Overview
Authors
Affiliations
The global burden due to microvascular complications in patients with diabetes mellitus persists and even increases alarmingly, the intervention and management are now encountering many difficulties and challenges. This paper reviews the recent advancement and progress in novel biomarkers, artificial intelligence technology, therapeutic agents and approaches of diabetic retinopathy and nephropathy, providing more insights into the management of microvascular complications.
Retinal Biomarkers in Diabetic Retinopathy: From Early Detection to Personalized Treatment.
Chondrozoumakis G, Chatzimichail E, Habra O, Vounotrypidis E, Papanas N, Gatzioufas Z J Clin Med. 2025; 14(4).
PMID: 40004872 PMC: 11856754. DOI: 10.3390/jcm14041343.
Zheng J, Zhang W, Miao Y, Li X, Luo W, Yang X Front Endocrinol (Lausanne). 2025; 15():1472967.
PMID: 39829954 PMC: 11738608. DOI: 10.3389/fendo.2024.1472967.
Shi S, Ding K, Chen F, Yang M, Ni L, Wu X Adipocyte. 2024; 13(1):2423723.
PMID: 39526504 PMC: 11556279. DOI: 10.1080/21623945.2024.2423723.
Lv B, Zuo H, Li Q, Huang F, Zhang T, Huang R World J Radiol. 2024; 16(9):407-417.
PMID: 39355394 PMC: 11440280. DOI: 10.4329/wjr.v16.i9.407.
Exploring the role of Müller cells-derived exosomes in diabetic retinopathy.
Gad M, Elsherbiny N, El-Bassouny D, Omar N, Mahmoud S, Al-Shabrawey M Microvasc Res. 2024; 154:104695.
PMID: 38723843 PMC: 11180575. DOI: 10.1016/j.mvr.2024.104695.